Allogene CFO Geoffrey Parker to Retire in November

Company: Allogene Therapeutics · Role: Chief Financial Officer · Departing Executive: Geoffrey Parker · Effective Date: November 6, 2026 · Date: September 2, 2026 Summary Allogene Therapeutics said Executive Vice President and Chief Financial Officer Geoffrey Parker will retire in all capacities effective November 6,…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Aureka Raises $100 Million for AI-Native Drug Discovery
MeiraGTx – $400M Oberland Strategic Financing for Late-Stage Gene Therapy Programs
Fulcrum Therapeutics and Slate Medicines Merge in $245 Million Migraine Reverse Merger
Beeline Therapeutics – $300M Launch